Buprenorphine Treatment Engagement and Overdose Prevention

Completed · Not applicable

Conditions studied: Opioid-use Disorder

In brief

Office-based buprenorphine could be expanded to treat many of the opioid users who are not in treatment and who are at great risk for opioid overdose, but effective approaches are needed to help individuals with opioid use disorder initiate and remain in office-based buprenorphine treatment. Investigators propose to develop and pilot test a novel intervention that will combine video-based directly observed therapy and incentives to promote buprenorphine treatment engagement and adherence in out-of-treatment opioid users.

Key facts

Study ID

NCT03677986

Run by

Johns Hopkins University

People needed

41

Starts

2019-05-01

Expected to finish

2020-10-20

Last updated by the study team

2024-02-20

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• opioid use disorder

You may not qualify if…

• current suicidal/homicidal ideation
• severe psychiatric disorder

Where it is running

• Center for Learning and Health — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.